Report cover image

Global Multiple Myeloma Therapeutics Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750278

Description

Global Multiple Myeloma Therapeutics Databank Market Report


The Multiple Myeloma Therapeutics market was valued at $19,054.2 Million in 2020, and is projected to reach $32,591.1 Million by 2029 growing at a CAGR of 6.19% from 2021 to 2029. Medication segment is expected to be the highest contributor to this market, with $8,265.9 Million in 2020, and is anticipated to reach $14,610.5 Million by 2029, registering a CAGR of 6.57%. Medication and Radiation Therapy segments collectively expected to account for about 78.9% share of the Multiple Myeloma Therapeutics market in 2020, with the former constituting around 43.4% share. Medication and Radiation Therapy segments are expected to witness significant growth rates at a CAGR of 6.57% and 6.28% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 78.9% in the overall Multiple Myeloma Therapeutics market in 2020, and is anticipated to reach 80.6% by 2029.

Table of Contents

100 Pages
1. Global Multiple Myeloma Therapeutics Market, By Type
1.1. Overview
1.2. Medication
1.2.1 Medication Market, By Region
1.2.1.1 North America Medication Market, By Country
1.2.1.2 Europe Medication Market, By Country
1.2.1.3 Asia-Pacific Medication Market, By Country
1.2.1.4 Rest of World Medication Market, By Country
1.3. Radiation Therapy
1.3.1 Radiation Therapy Market, By Region
1.3.1.1 North America Radiation Therapy Market, By Country
1.3.1.2 Europe Radiation Therapy Market, By Country
1.3.1.3 Asia-Pacific Radiation Therapy Market, By Country
1.3.1.4 Rest of World Radiation Therapy Market, By Country
1.4. Stem Cell Transplant
1.4.1 Stem Cell Transplant Market, By Region
1.4.1.1 North America Stem Cell Transplant Market, By Country
1.4.1.2 Europe Stem Cell Transplant Market, By Country
1.4.1.3 Asia-Pacific Stem Cell Transplant Market, By Country
1.4.1.4 Rest of World Stem Cell Transplant Market, By Country
1.5. Other Types
1.5.1 Other Types Market, By Region
1.5.1.1 North America Other Types Market, By Country
1.5.1.2 Europe Other Types Market, By Country
1.5.1.3 Asia-Pacific Other Types Market, By Country
1.5.1.4 Rest of World Other Types Market, By Country
2. Global Multiple Myeloma Therapeutics Market, By Diagnosis
2.1. Overview
2.2. Blood Tests
2.2.1 Blood Tests Market, By Region
2.2.1.1 North America Blood Tests Market, By Country
2.2.1.2 Europe Blood Tests Market, By Country
2.2.1.3 Asia-Pacific Blood Tests Market, By Country
2.2.1.4 Rest of World Blood Tests Market, By Country
2.3. Bone Marrow Biopsy
2.3.1 Bone Marrow Biopsy Market, By Region
2.3.1.1 North America Bone Marrow Biopsy Market, By Country
2.3.1.2 Europe Bone Marrow Biopsy Market, By Country
2.3.1.3 Asia-Pacific Bone Marrow Biopsy Market, By Country
2.3.1.4 Rest of World Bone Marrow Biopsy Market, By Country
2.4. Urine Tests
2.4.1 Urine Tests Market, By Region
2.4.1.1 North America Urine Tests Market, By Country
2.4.1.2 Europe Urine Tests Market, By Country
2.4.1.3 Asia-Pacific Urine Tests Market, By Country
2.4.1.4 Rest of World Urine Tests Market, By Country
2.5. Imaging Tests
2.5.1 Imaging Tests Market, By Region
2.5.1.1 North America Imaging Tests Market, By Country
2.5.1.2 Europe Imaging Tests Market, By Country
2.5.1.3 Asia-Pacific Imaging Tests Market, By Country
2.5.1.4 Rest of World Imaging Tests Market, By Country
2.6. Other Diagnosis
2.6.1 Other Diagnosis Market, By Region
2.6.1.1 North America Other Diagnosis Market, By Country
2.6.1.2 Europe Other Diagnosis Market, By Country
2.6.1.3 Asia-Pacific Other Diagnosis Market, By Country
2.6.1.4 Rest of World Other Diagnosis Market, By Country
3. Global Multiple Myeloma Therapeutics Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Multiple Myeloma Therapeutics Market, By Type
3.2.2 North America Multiple Myeloma Therapeutics Market, By Diagnosis
3.2.3 North America Multiple Myeloma Therapeutics Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Multiple Myeloma Therapeutics Market, By Type
3.2.3.1.2 U.S. Multiple Myeloma Therapeutics Market, By Diagnosis
3.2.3.2 Canada
3.2.3.2.1 Canada Multiple Myeloma Therapeutics Market, By Type
3.2.3.2.2 Canada Multiple Myeloma Therapeutics Market, By Diagnosis
3.2.3.3 Mexico
3.2.3.3.1 Mexico Multiple Myeloma Therapeutics Market, By Type
3.2.3.3.2 Mexico Multiple Myeloma Therapeutics Market, By Diagnosis
3.3. Europe
3.3.1 Europe Multiple Myeloma Therapeutics Market, By Type
3.3.2 Europe Multiple Myeloma Therapeutics Market, By Diagnosis
3.3.3 Europe Multiple Myeloma Therapeutics Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Multiple Myeloma Therapeutics Market, By Type
3.3.3.1.2 Germany Multiple Myeloma Therapeutics Market, By Diagnosis
3.3.3.2 France
3.3.3.2.1 France Multiple Myeloma Therapeutics Market, By Type
3.3.3.2.2 France Multiple Myeloma Therapeutics Market, By Diagnosis
3.3.3.3 U.K.
3.3.3.3.1 U.K. Multiple Myeloma Therapeutics Market, By Type
3.3.3.3.2 U.K. Multiple Myeloma Therapeutics Market, By Diagnosis
3.3.3.4 Italy
3.3.3.4.1 Italy Multiple Myeloma Therapeutics Market, By Type
3.3.3.4.2 Italy Multiple Myeloma Therapeutics Market, By Diagnosis
3.3.3.5 Spain
3.3.3.5.1 Spain Multiple Myeloma Therapeutics Market, By Type
3.3.3.5.2 Spain Multiple Myeloma Therapeutics Market, By Diagnosis
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Multiple Myeloma Therapeutics Market, By Type
3.3.3.6.2 Rest of Europe Multiple Myeloma Therapeutics Market, By Diagnosis
3.4. Asia-Pacific
3.4.1 Asia-Pacific Multiple Myeloma Therapeutics Market, By Type
3.4.2 Asia-Pacific Multiple Myeloma Therapeutics Market, By Diagnosis
3.4.3 Asia-Pacific Multiple Myeloma Therapeutics Market, By Country
3.4.3.1 China
3.4.3.1.1 China Multiple Myeloma Therapeutics Market, By Type
3.4.3.1.2 China Multiple Myeloma Therapeutics Market, By Diagnosis
3.4.3.2 India
3.4.3.2.1 India Multiple Myeloma Therapeutics Market, By Type
3.4.3.2.2 India Multiple Myeloma Therapeutics Market, By Diagnosis
3.4.3.3 Japan
3.4.3.3.1 Japan Multiple Myeloma Therapeutics Market, By Type
3.4.3.3.2 Japan Multiple Myeloma Therapeutics Market, By Diagnosis
3.4.3.4 Australia
3.4.3.4.1 Australia Multiple Myeloma Therapeutics Market, By Type
3.4.3.4.2 Australia Multiple Myeloma Therapeutics Market, By Diagnosis
3.4.3.5 South Korea
3.4.3.5.1 South Korea Multiple Myeloma Therapeutics Market, By Type
3.4.3.5.2 South Korea Multiple Myeloma Therapeutics Market, By Diagnosis
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Multiple Myeloma Therapeutics Market, By Type
3.4.3.6.2 Rest of Asia Multiple Myeloma Therapeutics Market, By Diagnosis
3.5. Rest of World
3.5.1 Rest of World Multiple Myeloma Therapeutics Market, By Type
3.5.2 Rest of World Multiple Myeloma Therapeutics Market, By Diagnosis
3.5.3 Rest of World Multiple Myeloma Therapeutics Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Multiple Myeloma Therapeutics Market, By Type
3.5.3.1.2 Brazil Multiple Myeloma Therapeutics Market, By Diagnosis
3.5.3.2 South Africa
3.5.3.2.1 South Africa Multiple Myeloma Therapeutics Market, By Type
3.5.3.2.2 South Africa Multiple Myeloma Therapeutics Market, By Diagnosis
3.5.3.3 GCC
3.5.3.3.1 GCC Multiple Myeloma Therapeutics Market, By Type
3.5.3.3.2 GCC Multiple Myeloma Therapeutics Market, By Diagnosis
3.5.3.4 RoW Countries
3.5.3.4.1 RoW Countries Multiple Myeloma Therapeutics Market, By Type
3.5.3.4.2 RoW Countries Multiple Myeloma Therapeutics Market, By Diagnosis
RoW Countries Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD LIST OF TABLES
TABLE 1. Global Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 2. Medication Market Value, By Region, 2020-2029, Million USD
TABLE 3. North America Medication Market Value, By Country, 2020-2029, Million USD
TABLE 4. Europe Medication Market Value, By Country, 2020-2029, Million USD
TABLE 5. Asia-Pacific Medication Market Value, By Country, 2020-2029, Million USD
TABLE 6. Rest of World Medication Market Value, By Country, 2020-2029, Million USD
TABLE 7. Radiation Therapy Market Value, By Region, 2020-2029, Million USD
TABLE 8. North America Radiation Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 9. Europe Radiation Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 10. Asia-Pacific Radiation Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 11. Rest of World Radiation Therapy Market Value, By Country, 2020-2029, Million USD
TABLE 12. Stem Cell Transplant Market Value, By Region, 2020-2029, Million USD
TABLE 13. North America Stem Cell Transplant Market Value, By Country, 2020-2029, Million USD
TABLE 14. Europe Stem Cell Transplant Market Value, By Country, 2020-2029, Million USD
TABLE 15. Asia-Pacific Stem Cell Transplant Market Value, By Country, 2020-2029, Million USD
TABLE 16. Rest of World Stem Cell Transplant Market Value, By Country, 2020-2029, Million USD
TABLE 17. Other Types Market Value, By Region, 2020-2029, Million USD
TABLE 18. North America Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 19. Europe Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 20. Asia-Pacific Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 21. Rest of World Other Types Market Value, By Country, 2020-2029, Million USD
TABLE 22. Global Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 23. Blood Tests Market Value, By Region, 2020-2029, Million USD
TABLE 24. North America Blood Tests Market Value, By Country, 2020-2029, Million USD
TABLE 25. Europe Blood Tests Market Value, By Country, 2020-2029, Million USD
TABLE 26. Asia-Pacific Blood Tests Market Value, By Country, 2020-2029, Million USD
TABLE 27. Rest of World Blood Tests Market Value, By Country, 2020-2029, Million USD
TABLE 28. Bone Marrow Biopsy Market Value, By Region, 2020-2029, Million USD
TABLE 29. North America Bone Marrow Biopsy Market Value, By Country, 2020-2029, Million USD
TABLE 30. Europe Bone Marrow Biopsy Market Value, By Country, 2020-2029, Million USD
TABLE 31. Asia-Pacific Bone Marrow Biopsy Market Value, By Country, 2020-2029, Million USD
TABLE 32. Rest of World Bone Marrow Biopsy Market Value, By Country, 2020-2029, Million USD
TABLE 33. Urine Tests Market Value, By Region, 2020-2029, Million USD
TABLE 34. North America Urine Tests Market Value, By Country, 2020-2029, Million USD
TABLE 35. Europe Urine Tests Market Value, By Country, 2020-2029, Million USD
TABLE 36. Asia-Pacific Urine Tests Market Value, By Country, 2020-2029, Million USD
TABLE 37. Rest of World Urine Tests Market Value, By Country, 2020-2029, Million USD
TABLE 38. Imaging Tests Market Value, By Region, 2020-2029, Million USD
TABLE 39. North America Imaging Tests Market Value, By Country, 2020-2029, Million USD
TABLE 40. Europe Imaging Tests Market Value, By Country, 2020-2029, Million USD
TABLE 41. Asia-Pacific Imaging Tests Market Value, By Country, 2020-2029, Million USD
TABLE 42. Rest of World Imaging Tests Market Value, By Country, 2020-2029, Million USD
TABLE 43. Other Diagnosis Market Value, By Region, 2020-2029, Million USD
TABLE 44. North America Other Diagnosis Market Value, By Country, 2020-2029, Million USD
TABLE 45. Europe Other Diagnosis Market Value, By Country, 2020-2029, Million USD
TABLE 46. Asia-Pacific Other Diagnosis Market Value, By Country, 2020-2029, Million USD
TABLE 47. Rest of World Other Diagnosis Market Value, By Country, 2020-2029, Million USD
TABLE 48. Global Multiple Myeloma Therapeutics Market Value, By Region, 2020-2029, Million USD
TABLE 49. North America Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 50. North America Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 51. North America Multiple Myeloma Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 52. U.S. Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 53. U.S. Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 54. Canada Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 55. Canada Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 56. Mexico Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 57. Mexico Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 58. Europe Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 59. Europe Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 60. Europe Multiple Myeloma Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 61. Germany Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 62. Germany Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 63. France Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 64. France Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 65. U.K. Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 66. U.K. Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 67. Italy Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 68. Italy Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 69. Spain Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 70. Spain Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 71. Rest of Europe Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 72. Rest of Europe Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 73. Asia-Pacific Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 74. Asia-Pacific Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 75. Asia-Pacific Multiple Myeloma Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 76. China Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 77. China Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 78. India Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 79. India Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 80. Japan Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 81. Japan Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 82. Australia Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 83. Australia Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 84. South Korea Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 85. South Korea Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 86. Rest of Asia Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 87. Rest of Asia Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 88. Rest of World Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 89. Rest of World Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 90. Rest of World Multiple Myeloma Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 91. Brazil Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 92. Brazil Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 93. South Africa Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 94. South Africa Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 95. GCC Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 96. GCC Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
TABLE 97. RoW Countries Multiple Myeloma Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 98. RoW Countries Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD
RoW Countries Multiple Myeloma Therapeutics Market Value, By Diagnosis, 2020-2029, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us